GE HealthCare Technologies Inc. $GEHC Shares Sold by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP lessened its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 99.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 4,322 shares of the company’s stock after selling 626,861 shares during the period. Westfield Capital Management Co. LP’s holdings in GE HealthCare Technologies were worth $325,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of GEHC. US Bancorp DE increased its holdings in shares of GE HealthCare Technologies by 1.1% in the 3rd quarter. US Bancorp DE now owns 320,586 shares of the company’s stock valued at $24,076,000 after acquiring an additional 3,461 shares during the period. RWA Wealth Partners LLC grew its position in GE HealthCare Technologies by 2.7% during the 3rd quarter. RWA Wealth Partners LLC now owns 6,374 shares of the company’s stock worth $479,000 after purchasing an additional 165 shares during the last quarter. Cary Street Partners Financial LLC increased its stake in GE HealthCare Technologies by 8.6% in the third quarter. Cary Street Partners Financial LLC now owns 2,796 shares of the company’s stock valued at $210,000 after purchasing an additional 221 shares during the period. Colonial Trust Advisors raised its holdings in shares of GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after buying an additional 139 shares during the last quarter. Finally, Tableaux LLC acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth about $301,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

GEHC has been the subject of several analyst reports. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Morgan Stanley boosted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday, February 4th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their price objective for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Citigroup upped their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Finally, Barclays raised their price target on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $84.27 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $90.26. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a 50-day moving average of $82.38 and a two-hundred day moving average of $78.41. The stock has a market cap of $38.41 billion, a P/E ratio of 18.48, a PEG ratio of 1.85 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the prior year, the firm earned $1.45 EPS. GE HealthCare Technologies’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.